Finding a key to unlock blocked differentiation in microRNA-deficient embryonic stem cells

November 15, 2017, University of Alabama at Birmingham
Rui Zhao. Credit: UAB

The more than 200 different types of human cells have the same DNA but express different ensembles of genes. Each cell type was derived from embryonic stem cells, which are called pluripotent stem cells because they can differentiate to all those different cell fates.

One very active area of biology is cells that mimic these fountainhead embryonic , cells that are called induced , or iPSCs. With genetic and biochemical tricks, researchers can reverse a differentiated cell—such as a skin fibroblast—into a pluripotent state.

Such iPSCs have the potential to create tissue for regenerative medicine, such as repair heart attacks, create models of human disease or make cells that enable drug screening. But future progress with iPSCs needs a much greater understanding of the basic biology of pluripotency and .

"For the goal of using stem cells in therapy, the most important step is differentiation from iPSCs," said Rui Zhao, Ph.D., an assistant professor of biochemistry and molecular genetics at the University of Alabama at Birmingham. "We need to be able to differentiate the iPSCs into a disease-relevant cell type at high efficiency and high purity."

In a study published in Stem Cell Reports, Zhao and colleagues have partly solved a long-unanswered basic question about stem cells—why are pluripotent stem cells that have mutations to block the production of microRNAs unable to differentiate?

Zhao and colleagues, including co-corresponding author Kitai Kim, Ph.D., of the Sloan Kettering Institute, have found a key that allows those microRNA-deficient pluripotent stem cells to differentiate into , including subtypes with markers for dopaminergic, glutamatergic and GABAergic neurons.

"For many years, we did not know why these cells did not differentiate," Zhao said. The answer for neural cell differentiation in the microRNA-deficient cells turned out to be simple—a single microRNA or a single protein.

In the Stem Cell Reports study, Zhao and colleagues show that a microRNA-302 mimic—delivered by a specially constructed lentivirus—was sufficient to enable neural differentiation of mouse that lacked Dgcr8, a vital gene for the processing of the more than 2,000 microRNAs in cells.

When they examined gene expression profiles in the , they saw changes in many gene sets regulated by p53, also known as . This tumor suppressor has been called "the guardian of the genome" because of its many roles in preventing DNA damage and cancer.

Zhao, Kim and colleagues showed that microRNA-302 acted to reduce p53 expression in the microRNA-deficient embryonic stem cells by binding to the 3' untranslated region of p53 mRNA.

They further showed that direct inhibition of p53 with the simian virus large T antigen or short hairpin RNA, or even deleting the p53 gene itself, allowed embryonic stem cells or iPSCs to proceed to neural differentiation without the need for microRNA-302. Thus, the differentiation barrier that prevents the neuronal lineage specification from microRNA-deficient stem cells is expression of p53.

The keys to unlock the paths to other cell lineage specifications from microRNA-deficient embryonic stem are still unknown, Zhao says.

Explore further: Improving the neuron factory—new modulator of stem cell identity found

More information: Zhong Liu et al, Elevated p53 Activities Restrict Differentiation Potential of MicroRNA-Deficient Pluripotent Stem Cells, Stem Cell Reports (2017). DOI: 10.1016/j.stemcr.2017.10.006

Related Stories

The protein TAZ sends 'mixed signals' to stem cells

September 6, 2017

Just as beauty exists in the eye of the beholder, a signal depends upon the interpretation of the receiver. According to new USC research published in Stem Cell Reports, a protein called TAZ can convey very different signals—depending ...

Vitamins and aminoacids regulate stem cell biology

February 16, 2017

An International Reserach Team coordinated by Igb-Cnr has discovered a key role of vitamins and amino acids in pluripotent stem cells. The research is published in Stem Cell Reports, and may provide new insights in cancer ...

Induced pluripotent stem cells at risk for rejection

May 13, 2011

(PhysOrg.com) -- Biologists at UC San Diego have discovered that an important class of stem cells known as "induced pluripotent stem cells," or iPSCs, derived from an individual's own cells, could face immune rejection problems ...

Recommended for you

How quinoa plants shed excess salt and thrive in saline soils

September 21, 2018

Barely heard of a couple of years ago, quinoa today is common on European supermarket shelves. The hardy plant thrives even in saline soils. Researchers from the University of Würzburg have now determined how the plant gets ...

Decoding the structure of an RNA-based CRISPR system

September 20, 2018

Over the past several years, CRISPR-Cas9 has moved beyond the lab bench and into the public zeitgeist. This gene-editing tool CRISPR-Cas9 holds promise for correcting defects inside individual cells and potentially healing ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.